Trial
NCT05652504
Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
Phase ISUSPENDEDREGULATORYConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
Malaria
Intervention
PfSPZ Vaccine
Why stopped
The study remains on hold due to a funding issue after it's been lifted by the FDA.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-02